NCT00850343View on ClinicalTrials.gov

Long-term Treatment Study of Certolizumab Pegol Without Coadministration of Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

208

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Certolizumab pegol

Subcutaneous (SC) injection

Trial Locations (8)

Unknown

Chubu Region

Chugoku Region

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Shikoku Region

Tohoku Region

Sponsors
All Listed Sponsors
collaborator

UCB Japan Co. Ltd.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY